• Profile
Close

Gonorrhoea and chlamydia diagnosis as an entry point for HIV pre-exposure prophylaxis: A modelling study

BMJ Open Mar 08, 2019

Kasaie P, et al. - In this investigation, researchers quantified the added value of targeting pre-exposure prophylaxis (PrEP) to men who have sex with men (MSM) who are infected with Neisseria gonorrhoeae/Chlamydia trachomatis (NG/CT) in terms of population-level impact over time on disease incidence. The implementation of PrEP has been modelled under three alternative scenarios: PrEP delivery at NG/CT diagnosis (targeted delivery), PrEP evaluation at NG/CT screening/testing, and PrEP evaluation in the general community (untargeted). Findings revealed that targeting MSM infected with NG/CT increases the efficiency and effectiveness of PrEP delivery. The diagnosis of NG/CT can be a highly effective entry point for PrEP initialization if high levels of sexually transmitted infection screening can be achieved at the community level.

Go to Original
Only Doctors with an M3 India account can read this article. Sign up for free or login with your existing account.
4 reasons why Doctors love M3 India
  • Exclusive Write-ups & Webinars by KOLs

  • Nonloggedininfinity icon
    Daily Quiz by specialty
  • Nonloggedinlock icon
    Paid Market Research Surveys
  • Case discussions, News & Journals' summaries
Sign-up / Log In
x
M3 app logo
Choose easy access to M3 India from your mobile!


M3 instruc arrow
Add M3 India to your Home screen
Tap  Chrome menu  and select "Add to Home screen" to pin the M3 India App to your Home screen
Okay